Related Experiment Video
Updated: Aug 19, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
Jason S Knight1, Nikhil Sharma, Erle S Robertson
1Department of Microbiology and Abramson Comprehensive Cancer Center, University of Pennsylvania Medical School, 201E Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA.
Abstract:
The stability of cell cycle checkpoint and regulatory proteins is controlled by the ubiquitin-proteasome degradation machinery. A critical regulator of cell cycle molecules is the E3 ubiquitin ligase SCFSkp2, known to facilitate the polyubiquitination and degradation of p27, E2F, and c-myc. SCFSkp2 is frequently deregulated in human cancers. In this study, we have revealed a novel link between the essential Epstein-Barr virus (EBV) nuclear antigen EBNA3C and the SCFSkp2 complex, providing a mechanism for cell cycle regulation by EBV. EBNA3C associates with cyclin A/cdk2 complexes, disrupting the kinase inhibitor p27 and enhancing kinase activity. The recruitment of SCFSkp2 activity to cyclin A complexes by EBNA3C results in ubiquitination and SCFSkp2-dependent degradation of p27. This is the first report of a viral protein usurping the function of the SCFSkp2 cell cycle regulatory machinery to regulate p27 stability, establishing the foundation for a mechanism by which EBV regulates cyclin/cdk activity in human cancers.
Insights
Epstein-Barr virus nuclear antigen 3C (EBNA3C) hijacks the SCFSkp2 complex to degrade the cell cycle inhibitor p27. This viral usurpation of the ubiquitin-proteasome system offers a new mechanism for EBV-driven cancer development.
Area of Science:
- Molecular Biology
- Virology
- Cancer Biology
Background:
- Cell cycle protein stability is regulated by the ubiquitin-proteasome system.
- The E3 ubiquitin ligase SCFSkp2 targets key cell cycle proteins like p27, E2F, and c-myc for degradation.
- Dysregulation of SCFSkp2 is implicated in human cancers.
Purpose of the Study:
- To investigate the role of Epstein-Barr virus (EBV) nuclear antigen 3C (EBNA3C) in cell cycle regulation.
- To elucidate the mechanism by which EBV influences the SCFSkp2 complex and its targets.
Main Methods:
- Investigated the association of EBNA3C with cyclin A/cdk2 complexes.
- Assessed the impact of EBNA3C on the stability of the kinase inhibitor p27.
- Examined the recruitment of SCFSkp2 activity to cyclin A complexes by EBNA3C.
Main Results:
- EBNA3C binds to cyclin A/cdk2 complexes, disrupting p27 and increasing kinase activity.
- EBNA3C facilitates the recruitment of SCFSkp2 to cyclin A complexes.
- This interaction leads to the ubiquitination and degradation of p27.
Conclusions:
- EBNA3C usurps the SCFSkp2 ubiquitin ligase machinery to control p27 stability.
- This represents a novel mechanism for EBV to regulate cell cycle progression.
- Understanding this interaction provides insights into EBV-associated oncogenesis.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Leaky Scanning
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Long-patch Base Excision Repair
Anaphase Promoting Complex
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...

